Mathias J. Rummel, Ann Janssens, David MacDonald, Mary‐Margaret Keating, Jan M. Zaucha, Jaclyn Davis, Janet Lasher, Chaitali Babanrao Pisal, Miguel Izquierdo & Jonathan W. Friedberg. (2021) A phase 3, randomized study of ofatumumab combined with bendamustine in rituximab‐refractory iNHL (COMPLEMENT A + B study). British Journal of Haematology 193:6, pages 1123-1133.
Crossref
Clément Bailly, Caroline Bodet-Milin, Caroline Rousseau, François Guerard, Thomas Carlier, Ludovic Ferrer, Nicolas Chouin, Joelle Gaschet, Ferid Haddad, Michel Cherel, Jacques Barbet, Françoise Kraeber-Bodéré & Mickaël Bourgeois. 2021. Cancer Immunology. Cancer Immunology
563
585
.
Douglas D. Richman, Richard J. Whitley & Frederick J. HaydenZeena Y. Nawas & Stephen K. Tyring. 2016. Clinical Virology. Clinical Virology
115
139
.
Wataru Oboshi, Toru Watanabe, Nobuyasu Yukimasa, Ichiro Ueno, Kensaku Aki, Tomoki Tada & Eiji Hosoi. (2016) SNPs rs4656317 and rs12071048 located within an enhancer in FCGR3A are in strong linkage disequilibrium with rs396991 and influence NK cell-mediated ADCC by transcriptional regulation. Human Immunology 77:10, pages 997-1003.
Crossref
Françoise Kraeber-Bodéré, Caroline Bodet-Milin, Caroline Rousseau, Thomas Carlier, Ludovic Ferrer, Nicolas Chouin, Férid Haddad, François Davodeau, Jean-François Chatal, Alain Faivre-Chauvet, Jean-François Gestin, Michel Chérel & Jacques Barbet. 2015. Cancer Immunology. Cancer Immunology
441
460
.
Robert F. Weiss, Merlin G. Miller, John F. Cronin, Harvey H. Hensley, Indira D. Joshi & Mitchell R. Smith. (2012) Parametric Model of Combination Therapy for Non-Hodgkin Lymphoma. PLoS ONE 7:12, pages e51736.
Crossref
Partha S. Chowdhury, Yan Chen, Chunning Yang, Kimberly E. Cook, Andrew C. Nyborg, Rachel Ettinger, Ronald Herbst, Peter A. Kiener & Herren Wu. (2012) Targeting the junction of CɛmX and ɛ-migis for the specific depletion of mIgE-expressing B cells. Molecular Immunology 52:3-4, pages 279-288.
Crossref
Henrik Gensicke, David Leppert, Özgür Yaldizli, Raija L.P. Lindberg, Matthias Mehling, Ludwig Kappos & Jens Kuhle. (2012) Monoclonal Antibodies and Recombinant Immunoglobulins for the Treatment of Multiple Sclerosis. CNS Drugs 26:1, pages 11-37.
Crossref
Françoise Kraeber-Bodéré, Alain Faivre-Chauvet, Caroline Bodet-Milin, Amandine Pallardy, William A. Wegener, Jean-Francois Chatal & David M. Goldenberg. 2014. Therapeutic Nuclear Medicine. Therapeutic Nuclear Medicine
551
556
.
Joseph M. Tuscano, Yunpeng Ma, Shiloh M. Martin, Jason Kato & Robert T. O’Donnell. (2011) The Bs20x22 anti-CD20-CD22 bispecific antibody has more lymphomacidal activity than do the parent antibodies alone. Cancer Immunology, Immunotherapy 60:6, pages 771-780.
Crossref
Shouvik Dass, Edward M. Vital & Paul Emery. 2011. Rheumatology. Rheumatology
563
570.e1
.
Ashwani K. Sood. (2009) PDEF and PDEF-induced proteins as candidate tumor antigens for T cell and antibody-mediated immunotherapy of breast cancer. Immunologic Research 46:1-3, pages 206-215.
Crossref
Brenda L. Bartlett & Stephen K. Tyring. 2009. Clinical Virology. Clinical Virology
109
.
Hakan M. Gürcan, Derin B. Keskin, Joel N.H. Stern, Matthew A. Nitzberg, Haris Shekhani & A. Razzaque Ahmed. (2009) A review of the current use of rituximab in autoimmune diseases. International Immunopharmacology 9:1, pages 10-25.
Crossref
Shouvik Dass, Edward M. Vital & Paul Emery. 2009. Rheumatoid Arthritis. Rheumatoid Arthritis
362
366
.
Robert M. Sharkey & David M. Goldenberg. (2008) Use of antibodies and immunoconjugates for the therapy of more accessible cancers. Advanced Drug Delivery Reviews 60:12, pages 1407-1420.
Crossref
Beverly Z Packard & Akira Komoriya. (2008) Intracellular protease activation in apoptosis and cell-mediated cytotoxicity characterized by cell-permeable fluorogenic protease substrates. Cell Research 18:2, pages 238-247.
Crossref
Jeffrey S. Ross. 2008. Pharmacogenomics and Personalized Medicine. Pharmacogenomics and Personalized Medicine
267
298
.
. (2007) Current Awareness in Hematological Oncology. Hematological Oncology 25:4, pages 204-211.
Crossref
B. Maecker & C. Klein. (2007) Lymphoproliferative Erkrankungen nach solider OrgantransplantationLymphoproliferative disorders after solid organ transplantation. Monatsschrift Kinderheilkunde 155:11, pages 1031-1039.
Crossref